14 & 15 June 2023 Palexpo, Geneva

Recipharm bolsters blow-fill-seal capabilities with Lab+

Global contract development and manufacturing organisation (CDMO) Recipharm, has bolstered its sterile filling capabilities by investing in Lab+ technology for low volume blow-fill-seal (BFS) filling at its facility in Kaysersberg, France.

BFS is an automated manufacturing process where plastic ampoules are blow-formed, filled, and sealed in a continuous operation. Recipharm offers sterile BFS contract manufacturing for a range of pharmaceutical products and applications including gels, solutions, suspensions, emulsions and aseptically packed single-use vaccines.

With a throughput speed of 2,000 doses per hour and a uniquely flexible design, Lab+ is ideal for BFS projects that require smaller volumes. Featuring a streamlined tooling changeover process, this technology can easily be adapted for a range of different product types and dosage designs. The system can also be charged with formulation using both conventional stainless-steel vessels or single-use charge bags from 200ml up to 20 Liters, streamlining the technical transfer process and enhancing flexibility.

Follow us:

Share this article:

LinkedIn
Twitter
Facebook